circRNA basic information
circBase ID: -
Name: hsa_circ_PAN3
Synonym: circ-PAN3
Host Gene: PAN3
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma / HCC
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

HCC tumor tissues; adjacent normal tissues

Cell lines:

Huh7; HCCLM3; SK-HEP-1; THLE-3

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: cyclin D1 / CCND1
Associated microRNA: miR-153
Biological function: promotes HCC cell proliferation and tumorigenesis; inhibits apoptosis; promotes cell cycle progression
Molecular mechanism: ceRNA mechanism: circ-PAN3 sponges miR-153 to upregulate cyclin D1 (CCND1)
Biological pathway or process:

proliferation (promotes); apoptosis (inhibits); cell cycle (promotes); ceRNA regulation (promotes)

Detected method:
Q
M
Validation methods:

Microarray; RT-qPCR; Clinical Sample Validation; Survival Analysis; Nuclear-Cytoplasmic Fractionation; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Luciferase Reporter Assay; RNA Pull-Down; Western Blot; In Vivo Animal Model

Clinical significance:

circ-PAN3 is increased in HCC clinical specimens and high circ-PAN3 is associated with poorer overall survival

Description:

circ-PAN3 is up-regulated in HCC tissues/cell lines and its high level predicts poorer overall survival. Functionally, circ-PAN3 promotes HCC growth by acting as a ceRNA that sponges miR-153, thereby relieving repression of cyclin D1 (CCND1) and enhancing cell-cycle progression and proliferation.

Confidence score:

0.7699

Other information
Title:

Circ-PAN3 facilitates hepatocellular carcinoma growth via sponging miR-153 and upregulating cyclin D1.

Journal: Oncology research
Published: 2025
PubMed ID: 39866238
Study type:

combined biological and clinical study

Data availability: The datasets generated and/or analyzed during the current study are not publicly available due to the need of permission from the IRB, but are available from the corresponding author on reasonable request (ryqin@tjh.tjmu.edu.cn).
Code availability: -